..................... 52 Heat Biologics, Inc. Investigational Product: Vesigenurtacel -L Protocol HS410 -101 CONFIDENTIAL Version 8.0; 03 Feb 2016 Page 16 of 86 9.0 CONCOMITANT MEDICATIONS AND NON -DRUG THERAPIES ................................ ......... 52 9.1 Permitted Medications and Non -Drug Therapies ................................ ................................ ........ 52 9.2 Prohibited Medications and Non -Drug Therapies ................................ ................................ .......52 9.3 Supportive Care ................................ ................................ ................................